Cardiogenic shock Trials in Paris, France
Conditions / Cardiogenic shock / Paris, France
Clinical trials for Cardiogenic shock investigate a range of treatment strategies and patient populations.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04020263 | Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock | RECRUITING | PHASE3 |
| NCT05586282 | Role of Candidate Proteins in Capillary Leakage During Acute Circulatory Failure | RECRUITING | — |
| NCT04366921 | European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO | UNKNOWN | — |
| NCT04548739 | Cerebral Autoregulation in Pediatric ECMO (ECMOX 2) | COMPLETED | — |
| NCT05750576 | Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate | COMPLETED | NA |
| NCT03551964 | Dual Antiplatelet Therapy For Shock Patients With Acute Myocardial Infarction | COMPLETED | PHASE4 |
| NCT03773822 | Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock. | COMPLETED | PHASE3 |
| NCT04082312 | Acute Kidney Injury in Adult Patients Supported by VA-ECMO | COMPLETED | — |
| NCT02754193 | Effects of Induced Moderate HYPOthermia on Mortality in Cardiogenic Shock Patients Rescued by Veno-arterial ExtraCorporeal Membrane Oxygenation (ECMO) | COMPLETED | NA |
| NCT06338345 | Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients | NOT_YET_RECRUITING | NA |